Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Regul Pept ; 110(1): 17-23, 2002 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-12468105

RESUMO

The effect of galanin (GAL) on vasopressin (VP) secretion was studied in 13-14-day cultures of isolated rat neurohypophyseal (NH) tissue. The VP content of the supernatant was determined by radioimmunoassay (RIA) after a 1- or 2-h incubation. A significantly decreased content of VP was detected following the administration of 10(-6)-10(-9) M doses of GAL. Dopamine (DA) and the DA-active drugs apomorphine (APM) and Pro-Lys-Gly (PLG) (10(-6) M in each medium) increased the VP level of NH tissue cultures. This VP concentration elevation could be blocked by the administration of GAL together with DA, APM or PLG. The DA-blocking effect of GAL was prevented by previous treatment with the GAL receptor antagonist galantid (M15). The results indicate that VP release is directly influenced by the GAL-ergic system. The GAL-ergic control of VP secretion from NH tissue in rats can occur independently of the hypothalamus, at the level of the posterior pituitary.


Assuntos
Antagonistas de Dopamina/farmacologia , Dopamina/farmacologia , Galanina/análogos & derivados , Galanina/farmacologia , Neuro-Hipófise/efeitos dos fármacos , Neuro-Hipófise/metabolismo , Substância P/análogos & derivados , Vasopressinas/metabolismo , Animais , Apomorfina/farmacologia , Técnicas de Cultura , Agonistas de Dopamina/farmacologia , Relação Dose-Resposta a Droga , Interações Medicamentosas , Galanina/antagonistas & inibidores , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Cinética , Masculino , Radioimunoensaio , Ratos , Ratos Wistar , Receptores de Neuropeptídeos/antagonistas & inibidores , Substância P/farmacologia
2.
Am J Physiol Regul Integr Comp Physiol ; 280(2): R458-65, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11208575

RESUMO

The plasma arginine vasopressin (AVP), ACTH, and corticosterone levels and the hypothalamic corticotropin-releasing hormone (CRH) content were measured after oral administration of 1 ml of 75% ethanol to rats, a model known to induce acute gastric erosions and stress. Elevated plasma AVP, ACTH, and corticosterone levels were detected 1 h after ethanol administration. Treatment with the vasopressin pressor (V(1)) receptor antagonist [d(CH(2))(5)Tyr(Me)-AVP] before ethanol administration significantly reduced the ACTH and corticosterone level increases. A higher hypothalamic CRH content was measured at 30 or 60 min after ethanol administration. V(1) receptor antagonist injection, 5 min before ethanol administration, inhibited the rise in hypothalamic CRH content. The protein synthesis blocker cycloheximide prevented the hypothalamic CRH content elevation after stress. The AVP-, CRH-, and AVP + CRH-induced in vitro ACTH release in normal anterior pituitary tissue cultures was also prevented by pretreatment with the V(1) receptor antagonist. The results support the hypothesis that stress-induced AVP may not only act directly on the ACTH producing anterior pituitary cells but also indirectly at the hypothalamic level via the synthesis and release of CRH.


Assuntos
Hormônio Adrenocorticotrópico/metabolismo , Intoxicação Alcoólica/fisiopatologia , Arginina Vasopressina/metabolismo , Corticosterona/metabolismo , Hormônio Liberador da Corticotropina/fisiologia , Sistema Hipotálamo-Hipofisário/fisiologia , Hipotálamo/fisiologia , Adeno-Hipófise/fisiologia , Receptores de Vasopressinas/fisiologia , Hormônio Adrenocorticotrópico/sangue , Intoxicação Alcoólica/sangue , Animais , Arginina Vasopressina/sangue , Arginina Vasopressina/farmacologia , Células Cultivadas , Corticosterona/sangue , Hormônio Liberador da Corticotropina/farmacologia , Cicloeximida/farmacologia , Sistema Hipotálamo-Hipofisário/fisiopatologia , Hipotálamo/efeitos dos fármacos , Masculino , Adeno-Hipófise/citologia , Adeno-Hipófise/efeitos dos fármacos , Ratos , Ratos Wistar , Receptores de Vasopressinas/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA